BlackRock Advisors’s Intermolecular, Inc. IMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-31,195
Closed -$72K 3834
2015
Q4
$72K Sell
31,195
-19,806
-39% -$41.4K ﹤0.01% 3065
2015
Q3
$96K Sell
51,001
-285,432
-85% -$597K ﹤0.01% 3122
2015
Q2
$663K Sell
336,433
-24,320
-7% -$45K ﹤0.01% 1969
2015
Q1
$592K Hold
360,753
﹤0.01% 1953
2014
Q4
$696K Hold
360,753
﹤0.01% 1742
2014
Q3
$837K Hold
360,753
﹤0.01% 1553
2014
Q2
$841K Sell
360,753
-9,379
-3% -$23.4K ﹤0.01% 1622
2014
Q1
$1.04M Buy
370,132
+25,291
+7% +$92.1K ﹤0.01% 1506
2013
Q4
$1.7M Buy
344,841
+5,423
+2% +$30.6K ﹤0.01% 1244
2013
Q3
$1.87M Buy
339,418
+145,861
+75% +$917K ﹤0.01% 1175
2013
Q2
$1.41M Buy
+193,557
New +$1.65M ﹤0.01% 1237

Other funds holding IMI

BlackRock Advisors's IMI Position: Q1 2016 in Review

BlackRock Advisors sold out of Intermolecular, Inc. (IMI) in Q1 2016, closing a stake of 31,195 shares — an estimated $72K sold.

BlackRock Advisors first reported a position in IMI in Q2 2013 and held it in 11 quarters. The position peaked at $1.87M in Q3 2013. 36 funds tracked by Wall St. Rank hold IMI as of Q1 2016.

  • BlackRock Advisors reported no remaining Intermolecular, Inc. position as of Q1 2016 after selling out during the quarter.
  • BlackRock Advisors sold 31,195 Intermolecular, Inc. shares in Q1 2016, an estimated $72K.
  • BlackRock Advisors first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 11 quarters.
  • BlackRock Advisors's Intermolecular, Inc. position peaked at $1.87M in Q3 2013.
  • 36 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q1 2016.

Based on BlackRock Advisors's 13F filing for Q1 2016, filed 10 May 2016.